Hepatitis D virus (HDV) is a satellite virus of the hepatitis B virus (HBV).
The HDV virus infects individuals chronically infected with HBV. HDV infection causes more serious liver disease that may progress to cirrhosis and hepatocellular carcinoma.
There are eight genotypes and all genotypes are detected using GenBio’s reagents. Anti-delta antibodies and RT-PCR is used for initial diagnosis. Subsequently , viral replication and monitoring of natural infection or antiviral treatment is based on quantitative dectection of viral RNA. After initial diagnosis, quantitative real time reverse transcription polymerase chain reaction (qRT-PCR) amplification is used to monitor treatment and prognosis. (See complete reagent list here.)
All reagents are made following ISO 13485 quality standards and detailed certificates of analysis and material safety data sheets are available. Reports describing use of these reagents are available here.